Aurinia Pharmaceuticals (AUPH) Amortization - Intangibles (2020 - 2021)
Aurinia Pharmaceuticals' (AUPH) quarterly Amortization - Intangibles came in at $524000.0 in Q4 2021, up 31.0% YoY from $400000.0 in Q4 2020, and up 4.8% on a QoQ basis from $500000.0 in Q3 2021.
Powered by 
Analysis
Aurinia Pharmaceuticals (AUPH) Amortization - Intangibles (2020 - 2021) Analysis & Trends
Aurinia Pharmaceuticals (AUPH) has 2 years of Amortization - Intangibles data on file, last reported at $524000.0 in Q4 2021.
- Quarterly Amortization - Intangibles rose 31.0% year-over-year to $524000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $2.0 million (up 55.55% YoY) and the FY2021 annual result came in at $2.1 million, up 61.54% from the prior year.
- Amortization - Intangibles climbed to $524000.0 in Q4 2021, from $500000.0 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $524000.0 in Q4 2021 to a low of $300000.0 in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Aurinia Pharmaceuticals | 2.10 Bn | 1.66 Bn | 76.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 500,000.00 |
| Sep 30, 2021 | 517,000.00 |
| Jun 30, 2021 | 536,000.00 |
| Mar 31, 2021 | 523,000.00 |
| Dec 31, 2020 | 398,000.00 |
| Sep 30, 2020 | 316,000.00 |
| Jun 30, 2020 | 300,000.00 |
| Mar 31, 2020 | 300,000.00 |